Latest Insider Transactions at Schwab Charles Corp (SCHW)
This section provides a real-time view of insider transactions for Schwab Charles Corp (SCHW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SCHWAB CHARLES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SCHWAB CHARLES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2025
|
Charles A. Ruffel Director |
SELL
Open market or private sale
|
Direct |
5,556
-25.08%
|
$483,372
$87.65 P/Share
|
|
May 19
2025
|
Walter W Bettinger Co-Chairman |
SELL
Open market or private sale
|
Direct |
191,523
-20.03%
|
$17,045,547
$89.0 P/Share
|
|
May 16
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
18,010
-1.08%
|
$1,584,880
$88.74 P/Share
|
|
May 13
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
80,000
-0.14%
|
-
|
|
May 12
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
120,000
-0.2%
|
$10,200,000
$85.39 P/Share
|
|
May 09
2025
|
Richard A Wurster President & CEO |
SELL
Open market or private sale
|
Direct |
15,345
-7.95%
|
$1,288,980
$84.08 P/Share
|
|
May 08
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
8,613
-16.87%
|
$732,105
$85.0 P/Share
|
|
May 08
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,613
+20.32%
|
$353,133
$41.98 P/Share
|
|
May 08
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
6,000
-0.01%
|
-
|
|
May 08
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
25,000
-29.76%
|
$2,125,000
$85.0 P/Share
|
|
May 08
2025
|
Nigel J Murtagh Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+22.94%
|
$1,050,000
$42.99 P/Share
|
|
May 08
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect |
3,658
-16.84%
|
$310,930
$85.0 P/Share
|
|
May 08
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
3,658
+7.62%
|
$160,952
$44.24 P/Share
|
|
May 07
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
62,500
-0.11%
|
-
|
|
May 06
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Bona fide gift
|
Direct |
121
-0.2%
|
-
|
|
May 06
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
80,000
-0.14%
|
-
|
|
May 05
2025
|
Richard A Wurster President & CEO |
SELL
Bona fide gift
|
Direct |
2,877
-1.47%
|
-
|
|
May 05
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
75,000
-0.13%
|
-
|
|
May 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
11,994
-11.6%
|
$971,514
$81.58 P/Share
|
|
May 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,614
+20.33%
|
$353,174
$41.98 P/Share
|
|
May 01
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.41%
|
$1,944,000
$81.14 P/Share
|
|
May 01
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
9,559
-100.0%
|
$783,838
$82.0 P/Share
|
|
May 01
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
9,559
+100.0%
|
$401,478
$42.99 P/Share
|
|
Apr 30
2025
|
Charles R. Schwab Co-Chairman |
SELL
Bona fide gift
|
Indirect |
625,000
-1.04%
|
-
|
|
Apr 28
2025
|
Charles R. Schwab Co-Chairman |
SELL
Open market or private sale
|
Indirect |
37,585
-0.06%
|
$2,969,215
$79.55 P/Share
|
|
Apr 22
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
6,897
-0.44%
|
$524,172
$76.77 P/Share
|
|
Apr 22
2025
|
Carolyn Schwab Pomerantz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,897
+45.8%
|
$213,807
$31.37 P/Share
|
|
Apr 21
2025
|
Frank C Herringer Director |
SELL
Open market or private sale
|
Indirect |
3,592
-2.04%
|
$265,808
$74.26 P/Share
|
|
Apr 21
2025
|
Frank C Herringer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,548
+48.15%
|
$264,988
$31.21 P/Share
|
|
Apr 03
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-0.7%
|
$1,800,000
$75.05 P/Share
|
|
Apr 01
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,380
-3.46%
|
$260,260
$77.66 P/Share
|
|
Mar 31
2025
|
Todd M Ricketts Director |
BUY
Bona fide gift
|
Direct |
290,608
+35.6%
|
-
|
|
Mar 24
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
8,614
-14.9%
|
$689,120
$80.0 P/Share
|
|
Mar 24
2025
|
Paul V Woolway MD, Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,614
+20.33%
|
$353,174
$41.98 P/Share
|
|
Mar 14
2025
|
Charles A. Ruffel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,584
+27.93%
|
$369,112
$43.21 P/Share
|
|
Mar 06
2025
|
Carolyn Schwab Pomerantz Director |
SELL
Open market or private sale
|
Indirect |
24,000
-1.37%
|
$1,800,000
$75.58 P/Share
|
|
Mar 06
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
23,258
-100.0%
|
$1,744,350
$75.59 P/Share
|
|
Mar 05
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
9,887
-17.1%
|
$741,525
$75.38 P/Share
|
|
Mar 05
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
15,229
-20.49%
|
$1,142,175
$75.38 P/Share
|
|
Mar 03
2025
|
Nigel J Murtagh Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,277
-13.17%
|
$890,883
$79.05 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Open market or private sale
|
Indirect |
28,668
-55.21%
|
$2,264,772
$79.32 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
BUY
Exercise of conversion of derivative security
|
Direct |
28,668
+100.0%
|
$1,204,056
$42.99 P/Share
|
|
Mar 03
2025
|
Jonathan M. Craig MD, Head of Investor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
19,151
-100.0%
|
$1,512,929
$79.05 P/Share
|
|
Mar 03
2025
|
Richard A Wurster President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
34,608
-15.01%
|
$2,734,032
$79.05 P/Share
|
|
Mar 03
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Open market or private sale
|
Indirect |
3,380
-5.52%
|
$267,020
$79.32 P/Share
|
|
Mar 03
2025
|
Paul V Woolway MD, Chief Banking Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,367
-8.77%
|
$265,993
$79.05 P/Share
|
|
Mar 03
2025
|
Walter W Bettinger Co-Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
96,539
-9.17%
|
$7,626,581
$79.05 P/Share
|
|
Mar 03
2025
|
Peter J. Morgan Iii General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,378
-45.15%
|
$661,862
$79.05 P/Share
|
|
Mar 03
2025
|
Charles R. Schwab Co-Chairman |
BUY
Payment of exercise price or tax liability
|
Direct |
26,075
+100.0%
|
$2,059,925
$79.05 P/Share
|
|
Mar 01
2025
|
Jonathan S Beatty MD, Head of Advisor Services |
SELL
Payment of exercise price or tax liability
|
Direct |
2,088
-4.49%
|
$164,952
$79.05 P/Share
|